Cronos Group Inc CRON
News
Cannabis stocks drop sharply as DEA sets drug-rescheduling hearing after November election
Canopy Growth stock drops on wider-than-expected loss but company sees growth opportunities in U.S. markets
Cronos Group Reports 2024 Second Quarter Results
How the head of cannabis company Cronos dealt with a negative report from indicted short seller Andrew Left
Cronos Group Inc. to Hold 2024 Second Quarter Earnings Conference Call on August 8, 2024
Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders
Cronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of Shareholders
Legal cannabis sales eat into beer revenue, survey data shows
Cannabis company Canopy Growth loss narrows as operating expenses drop
Cronos's stock leaps as strong cannabis-flower sales lead to record revenue
Cannabis stocks rally after report that DEA will reclassify drug as less dangerous
Aurora leads Canadian cannabis stocks higher after pot trade group beefs up ranks with industry exec
Toronto Stocks Advance; Canadian Imperial Bank of Commerce Up on 1Q Profit, Revenue Rise
Curaleaf, Truelive, Verano could benefit from marijuana reclassification
Green Thumb, Trulieve and other cannabis stocks up as much as 23% as details emerge on HHS recommendation to lower drug classification
Canadian cannabis company Cronos Group sells Peace Naturals campus for about $17M
Organigram's stock soars as British American Tobacco invests $91.3 million
Cronos stock climbs after launching Peace Naturals medical cannabis brand in Germany
Canopy Growth stock soars on heavy volume again, amid cannabis investor optimism over possible favorable legislation